Essential Partners’s Eikon Therapeutics EIKN Stock Holding History

Essential Partners’s Portfolio EIKN Stock Details EIKN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$121	Buy	+15	New	+$151	﹤0.01%	2677

Other funds holding EIKN

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Essential Partners's EIKN Position: Q3 2026 in Review

Essential Partners opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 15 shares worth $121. The stake represents ﹤0.01% of the portfolio and ranks #2677 among its holdings.

10 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

Essential Partners held 15 shares of Eikon Therapeutics worth $121 as of Q3 2026.
Eikon Therapeutics was a new Essential Partners position in Q3 2026.
Eikon Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2677 holding.
10 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.